Who Paid My Doc
VNS Therapy
Device Cardiology/Vascular Diseases
General payments
$25,685,874
Research payments
$13,144,972
Through program year 2023, $25,685,874 in general payments and $13,144,972 in research payments were reported against VNS Therapy (Cardiology/Vascular Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $368,106 | 1,302 |
| 2023 | Research | $4,000,852 | 423 |
| 2022 | General | $321,372 | 1,049 |
| 2022 | Research | $2,122,416 | 436 |
| 2021 | General | $3,225 | 2 |
| 2020 | General | $10,960,551 | 3,666 |
| 2020 | Research | $3,926,344 | 689 |
| 2019 | General | $14,032,620 | 8,725 |
| 2019 | Research | $3,095,360 | 424 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.
The top 5 of 23 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 42 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
14,744 general · 1,972 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.